These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 14975257)

  • 1. Interactions of immunoglobulins outside the antigen-combining site.
    Nezlin R; Ghetie V
    Adv Immunol; 2004; 82():155-215. PubMed ID: 14975257
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological analogues of drug-receptor interaction.
    Alonso de Florida F
    Bol Estud Med Biol; 1983; 32(7-8 Suppl 1):3-51. PubMed ID: 6085719
    [No Abstract]   [Full Text] [Related]  

  • 3. Structure-function relationships in immunoglobulins.
    Dwek RA; Sutton BJ; Perkins SJ; Rademacher TW
    Biochem Soc Symp; 1984; 49():123-36. PubMed ID: 6400488
    [No Abstract]   [Full Text] [Related]  

  • 4. Introduction to antibodies and complement.
    Moulds JM
    Transfus Apher Sci; 2009 Jun; 40(3):185-8. PubMed ID: 19410515
    [No Abstract]   [Full Text] [Related]  

  • 5. [Complement-binding capacity of aggregated immunoglobulins of different molecular weights].
    Konstantinova NA; Ostreĭko KK; Tumanova IA; Lavret'ev VV; Petrov RV
    Biull Eksp Biol Med; 1982 Dec; 94(12):73-5. PubMed ID: 7150770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Humoral immunity].
    Pasquali JL; Korganow AS
    Rev Prat; 1998 Feb; 48(3):337-42. PubMed ID: 9781085
    [No Abstract]   [Full Text] [Related]  

  • 7. Interactions of histidine-rich glycoprotein with immunoglobulins and proteins of the complement system.
    Manderson GA; Martin M; Onnerfjord P; Saxne T; Schmidtchen A; Mollnes TE; Heinegård D; Blom AM
    Mol Immunol; 2009 Oct; 46(16):3388-98. PubMed ID: 19674792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and genetic insights into antibody complementarity.
    Kabat EA
    Prog Clin Biol Res; 1980; 42():1-46. PubMed ID: 6771768
    [No Abstract]   [Full Text] [Related]  

  • 9. Generation and expression of a minimal hybrid Ig-receptor formed between single domains from proteins L and G.
    Harrison SL; Housden NG; Bottomley SP; Cossins AJ; Gore MG
    Protein Expr Purif; 2008 Mar; 58(1):12-22. PubMed ID: 18158250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Defense mechanisms in invertebrates and fish].
    Mori K; Nakanishi T; Suzuki T; Oohara I
    Tanpakushitsu Kakusan Koso; 1989 Mar; 34(3):214-23. PubMed ID: 2734455
    [No Abstract]   [Full Text] [Related]  

  • 11. [Structure and function of immunoglobulins].
    Seiler FR
    Beitr Infusionther Klin Ernahr; 1982; 9():1-15. PubMed ID: 6816212
    [No Abstract]   [Full Text] [Related]  

  • 12. Increasing diversity of animal lectin structures.
    Drickamer K
    Curr Opin Struct Biol; 1995 Oct; 5(5):612-6. PubMed ID: 8574696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramolecular signaling in immunoglobulins -- new evidence emerging from the use of supramolecular protein ligands.
    Piekarska B; Konieczny L; Rybarska J; Stopa B; Spólnik P; Roterman I; Król M
    J Physiol Pharmacol; 2004 Sep; 55(3):487-501. PubMed ID: 15381822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Binding Kinetics and Thermodynamics of Antibody-Antigen Interactions and Interactions Involving Complement Proteins.
    Rossini S; Dimitrov JD
    Methods Mol Biol; 2021; 2227():237-247. PubMed ID: 33847946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell surface receptors--structure and function.
    Kornfeld S; Kornfeld R
    Prog Hematol; 1971; 7():161-83. PubMed ID: 4363290
    [No Abstract]   [Full Text] [Related]  

  • 16. [Peptide regulators originating from nonspecialized protein precursors].
    Iankovskiĭ OIu
    Zh Evol Biokhim Fiziol; 1985; 21(1):62-9. PubMed ID: 3885636
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of SynCAM surface trafficking using a SynCAM derived ligand with high homophilic binding affinity.
    Breillat C; Thoumine O; Choquet D
    Biochem Biophys Res Commun; 2007 Aug; 359(3):655-9. PubMed ID: 17548061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Not only immunoglobulins, C-reactive protein too.
    Agrawal A
    Mol Immunol; 2013 Dec; 56(4):561-2. PubMed ID: 23911413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme-inhibiting antibodies and immunoglobulin combining site functional perspectives.
    Petrella RU; Iwamoto M; Yokoyama MM
    Kurume Med J; 1990; 37(4):209-28. PubMed ID: 1711138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Complement consumption as criterion of the tolerogenicity of a globulin preparation].
    Shemerovskaia TG; Sofronov BN
    Biull Eksp Biol Med; 1983 May; 95(5):71-3. PubMed ID: 6850093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.